维普期刊资源整合服务平台（V6.5）

62篇 您的检索式：作者名="CUSTODIS F"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	HMG-CoA reductase inhibitors in chronic heart failure : potential mechanisms of benefit and risk 显示文摘	Laufs U Custodis F Bohm M	2006	Drugs2006，66，2：	1
2	Role of Rac1 GTPase activation in atrial fibrillation显示文摘	Adam O Frost G Custodis F	2007	Am Coll Cardiol2007，50，4：	1
3	Heart rate reduction in cardiovascular disease and therapy显示文摘	Reil JC Custodis F Swedberg K	2011	Clin Res Cardiol2011，100，1：	1
4	Heart rate reduction by ivabradine reduces oxidative stress,im- proves endothelial function,and prevents atherosclerosis in apolipoprote in E-deficient mice 显示文摘	Custodis F Baumhakel M Schlimmer N	2008	Circulation2008，117，18：	1
5	Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atheroxclerotic plaque load in ApoE-knoekout mice 显示文摘	Baumhakel M Custodis F Sehlimmer N	2010	Atherosclerosis2010，212，1：	1
6	Heart rate redu- etion by ivabradine reduces oxidative stress, improves endothelial funetion, and prevents atherosclerosis in apolipprotein e-deficient mice显示文摘	Custodis F Baumhakel M Sehlimmer N	2008	Circulation2008，117，11：	1
7	HMG-CoA reductase inhibitor in chronic heart failure: potential mechanisms of benefit and risk显示文摘	Laufs U Custodis F Bohm M	2006	Drugs2006，66，：	1
8	Heart rate reduction by ivabradine reduces oxidative stress,improvesendothelial function,and prevents atheresclerosis in apolipoprotein E-deficient mice显示文摘	Custodis F Baumhakel M Schlimmer N	2008	Circulation2008，117，18：	1
9	Heart rate reduction by ivabradine improves aortic compliance in apolipoprotein E-defi- cient mice显示文摘	Custodis F Fries P Muller A	2012	J Vase Res2012，49，5：	1
10	HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk显示文摘	Laufs U Custodis F Bohm M	2006	Drugs2006，66，2：	1
11	HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk 显示文摘	Laufs U Custodis F Bohm M	2006	Drugs2006，66，2：	1
12	Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice显示文摘	Custodis F Baumhakel M Schlimmer N	2008	Circulation2008，117，18：	1
13	Role of Racl GTPase activation in atrial fibrillation 显示文摘	ADAM O FROST G CUSTODIS F	2007	J Am Coll Cardiol2007，50，4：	1
14	HMG - CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk 显示文摘	Laufs u Custodis F Bohm M	2006	Drug2006，66，2：	1
15	Stress wor- sens endothelial function and ischemic stroke via glucocorti- coids显示文摘	BALKAYA M PRINZ V CUSTODIS F	2011	Stroke2011，42，11：	1
16	HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk显示文摘	Laufs U Custodis F Bohm M	2006	Drug2006，66，2：	1
17	Vascular pathophysiology in response to increased heart rate 显示文摘	Custodis F Schirmer SH Baumhakel M	2010	J Am Coll Cardiol2010，56，24：	1
18	Role of RacI GTPase activation in atrial fibrillation 显示文摘	Adam O Frost G Custodis F	2007	J Am Coil Cardiol2007，50，4：	1
19	HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk显示文摘	LAUFS U CUSTODIS F BOHM M	2006	Drugs2006，66，2：	1
20	HMG-CoA reductase inhibitors in chronic heart failure:potential mechanisms of benefit and risk显示文摘	Laufs U Custodis F Bohm M	2006	Drugs2006，66，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示